GALMED PHARMACEUTICALS LTD. Debt Securities, Available-for-sale, Unrealized Loss
GALMED PHARMACEUTICALS LTD. (GLMD) reported Debt Securities, Available-for-sale, Unrealized Loss of $379.00 thousand for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-31.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AvailableForSaleDebtSecuritiesGrossUnrealizedLoss · last filed 2026-03-31
| Period end | Debt Securities, Available-for-sale, Unrealized Loss 12 month |
|---|---|
| 2025-12-31 | $379.00K 20-F · filed 2026-03-31 |
| 2024-12-31 | $451.00K 20-F · filed 2026-03-31 |
| 2023-12-31 | $470.00K 20-F · filed 2025-04-02 |
| 2022-12-31 | $775.00K 20-F · filed 2024-04-04 |
| 2021-12-31 | $238.00K 20-F · filed 2023-03-29 |
| 2020-12-31 | $33.00K 20-F · filed 2022-05-02 |
| 2019-12-31 | $37.00K 20-F · filed 2021-03-18 |
| 2018-12-31 | $67.00K 20-F · filed 2020-03-12 |